Final Top-Line Results Of The Bgbc008 Phase II, Multicenter Study Of Bemcentinib And Pembrolizumab (Bem+Pembro) In Second-Line (2L) Advanced Non-Squamous (Ns) Non-Small Cell Lung Cancer (Nsclc) (Nct03184571)
Bemcentinib;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Final Top-Line Results Of The Bgbc008 Phase II, Multicenter Study Of Bemcentinib And Pembrolizumab (Bem+Pembro) In Second-Line (2L) Advanced Non-Squamous (Ns) Non-Small Cell Lung Cancer (Nsclc) (Nct03184571) ### Output: Bemcentinib;Pembrolizumab